BOTULINUM TOXIN A AS AN COADJUVANT IN THE TREATMENT OF CHRONIC HEADACHE: A Review
DOI:
https://doi.org/10.61164/rmnm.v13i1.1942Keywords:
Botulinum toxin, Migraine, headache disordersAbstract
Migraine is one of the most well-known headaches in the world. Despite not having a specific test, the diagnosis can be made quickly during a medical consultation, with accurate information provided by the patient. Over the years, botulinum toxin has been used mainly for aesthetic treatments, but research shows its effectiveness when used as an ally in the treatment of migraines. The objective of this work is to synthesize in a literature review the existing information related to the treatment of migraine using Botulinum Toxin A (TB-A). Literature review (2018 to 2021) using databases Medline, PubMed, SciELO, ScienceDirect and Portland Press, with the descriptors “botulinum toxin A, headache disorders, migraine” in Portuguese and English. It is concluded that the use of botulinum toxin A in the treatment of migraine affects the frequency and intensity of pain, being considered the safest and most effective current treatment when compared to the other therapeutic methods mentioned in the present study.
References
RAJ KUMAR; Therapeutic use of botulinum toxin in pain treatment. Neuronal Signaling, 28 set. 2018. Disponível em: https:/doi.org/10.1042/NS20180058 Acesso em: 15 out. 2023. DOI: https://doi.org/10.1042/NS20180058
Biblioteca Virtual de Saúde, Enxaqueca. 2014. Fonte: Sociedade Brasileira de Cefaleia. Disponível em: https://bvsms.saude.gov.br/enxaqueca/. Acesso em: 08 abr. 2023.
MATAK et al. Mechanisms of Botulinum Toxin Type A Action on Pain. Toxins, Croácia, v. 11, n. 8, p. 459-482, 5 ago. 2019. Disponível em: https://doi.org/10.3390/toxins11080459. Acesso em: 16 out. 2023. DOI: https://doi.org/10.3390/toxins11080459
RYU, Jae Hyung et al. Ultrasound-guided greater occipital nerve block with chronic headache in the occipital area: a randomized controlled trial. Korean Journal Of Anesthesiology. Korea, p. 479-485. out. 2019. Disponível em: https://doi.org/10.4097/kja.19145. Acesso em: 10 abr. 2023. DOI: https://doi.org/10.4097/kja.19145
ZIROVICH, Milena D. et al. Botulinum Toxin Type A for the Treatment of Post-traumatic Headache: a randomized, placebo-controlled, cross-over study. Military Medicine. United States, p. 493-499. maio 2021. Disponível em: https://doi.org/10.1093/milmed/usaa391. Acesso em: 20 abr. 2023. DOI: https://doi.org/10.1093/milmed/usaa391
KIM, Hyeyun et al. Botulinum Toxin Type-A (Botulax®) Treatment in Patients with Intractable Chronic Occipital Neuralgia: a pilot study. Toxins, Korea, v. 13, n. 5, p. 332-337, 4 maio 2021. Disponível em: https://doi.org/10.3390/toxins13050332. Acesso em: 15 out. 2023. DOI: https://doi.org/10.3390/toxins13050332
SANZ, A. Castrillo et al. Experiencia con toxina botulínica en la migraña crónica. Neurología, Segovia, v. 33, n. 8, p. 499-504, out. 2018. Disponível em: https://doi.org/10.1016/j.nrl.2016.09.004. Acesso em: 16 out. 2023. DOI: https://doi.org/10.1016/j.nrl.2016.09.004
STARK, Catherine et al. Real-world effectiveness of onabotulinumtoxinA treatment for the prevention of headaches in adults with chronic migraine in Australia: a retrospective study. The Journal Of Headache And Pain, Australia, v. 20, n. 1, p. 1-10, 15 jul. 2019. Disponível em: https://doi.org/10.1186/s10194-019-1030-z. Acesso em: 16 out. 2023. DOI: https://doi.org/10.1186/s10194-019-1030-z
Mendes, K. D. S., Silveira, R. C. C. P., & Galvão, C. M. (2008). Integrative literature review: a research method to incorporate evidence in health care and nursing. Texto & Contexto - Enfermagem, 17(4), 758-764. DOI: https://doi.org/10.1590/S0104-07072008000400018
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Revista Multidisciplinar do Nordeste Mineiro
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
